drugset / Trial / NCT02856594

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep

NCT02856594 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to determine whether, compared with placebo, the nighttime administration of a intravenous dexmedetomidine is effective at inducing sleep and preventing postoperative delirium in extubated post-cardiac surgical patients.

Timeline

Start
2017-03-06
Primary completion
2022-02-11
Completion
2022-02-16

Outcome

Met primary endpoint

registry analysis (superiority test); Dexmedetomidine-induced Sleep vs Placebo; p = 0.029; Odds Ratio (OR) 0.32 (95% CI 0.10 to 0.83); Regression, Logistic NCT02856594 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg Intravenous

Indications